U.S. flag

An official website of the United States government

NM_000249.4(MLH1):c.56T>A (p.Ile19Asn) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 25, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002347565.2

Allele description [Variation Report for NM_000249.4(MLH1):c.56T>A (p.Ile19Asn)]

NM_000249.4(MLH1):c.56T>A (p.Ile19Asn)

Gene:
MLH1:mutL homolog 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000249.4(MLH1):c.56T>A (p.Ile19Asn)
HGVS:
  • NC_000003.12:g.36993603T>A
  • NG_007109.2:g.5254T>A
  • NG_008418.1:g.4702A>T
  • NM_000249.4:c.56T>AMANE SELECT
  • NM_001167617.3:c.-461T>A
  • NM_001167618.3:c.-890T>A
  • NM_001167619.3:c.-803T>A
  • NM_001258271.2:c.56T>A
  • NM_001258273.2:c.-577T>A
  • NM_001258274.3:c.-1040T>A
  • NM_001354615.2:c.-571T>A
  • NM_001354616.2:c.-571T>A
  • NM_001354617.2:c.-663T>A
  • NM_001354618.2:c.-895T>A
  • NM_001354619.2:c.-1019T>A
  • NM_001354620.2:c.-229T>A
  • NM_001354621.2:c.-988T>A
  • NM_001354622.2:c.-1101T>A
  • NM_001354623.2:c.-1010T>A
  • NM_001354624.2:c.-771T>A
  • NM_001354625.2:c.-669T>A
  • NM_001354626.2:c.-766T>A
  • NM_001354627.2:c.-998T>A
  • NM_001354628.2:c.56T>A
  • NM_001354629.2:c.56T>A
  • NM_001354630.2:c.56T>A
  • NP_000240.1:p.Ile19Asn
  • NP_000240.1:p.Ile19Asn
  • NP_001245200.1:p.Ile19Asn
  • NP_001341557.1:p.Ile19Asn
  • NP_001341558.1:p.Ile19Asn
  • NP_001341559.1:p.Ile19Asn
  • LRG_216t1:c.56T>A
  • LRG_216:g.5254T>A
  • LRG_216p1:p.Ile19Asn
  • NC_000003.11:g.37035094T>A
  • NM_000249.3:c.56T>A
Protein change:
I19N
Molecular consequence:
  • NM_001167617.3:c.-461T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001167618.3:c.-890T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001167619.3:c.-803T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001258273.2:c.-577T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001258274.3:c.-1040T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354615.2:c.-571T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354616.2:c.-571T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354617.2:c.-663T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354618.2:c.-895T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354619.2:c.-1019T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354620.2:c.-229T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354621.2:c.-988T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354622.2:c.-1101T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354623.2:c.-1010T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354624.2:c.-771T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354625.2:c.-669T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354626.2:c.-766T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001354627.2:c.-998T>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000249.4:c.56T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258271.2:c.56T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354628.2:c.56T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354629.2:c.56T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354630.2:c.56T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002650098Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Jun 25, 2019) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002650098.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.I19N variant (also known as c.56T>A), located in coding exon 1 of the MLH1 gene, results from a T to A substitution at nucleotide position 56. The isoleucine at codon 19 is replaced by asparagine, an amino acid with dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024